Moderna to Deliver 20 Million Doses of COVID-19 Vaccine to Argentina
Moderna announces supply agreement with the Argentina government for 20 million doses of Moderna’s COVID-19 vaccine.
Moderna. announced a supply agreement in a July 12, 2021 press release with the government of Argentina for 20 million doses of Moderna’s COVID-19 vaccine or its updated variant booster vaccine candidate, if authorized. Delivery will begin the first quarter of 2022.
“We appreciate the support from the government of Argentina with this supply agreement for doses of the Moderna COVID-19 vaccine or our variant booster candidates,” said Stéphane Bancel, Chief Executive Officer of Moderna, in a press release. “We are committed to making our vaccine available around the world as we seek to address the pandemic with our COVID-19 vaccine.”
The Moderna COVID-19 vaccine is an mRNA vaccine against COVID-19 encoding for a prefusion stabilized form of the spike protein. Moderna has received emergency authorization for the vaccine for adults from health agencies in more than 50 countries and an Emergency Use Listing from WHO.
Source: Moderna
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
EMA Recommends Imfinzi-Based Perioperative Regimen for Treating Resectable NSCLC
March 10th 2025The committee’s recommendation is based on results from a Phase III trial in which Imfinzi demonstrated a reduced risk of recurrence, progression, or death by 32% compared to neoadjuvant chemotherapy alone.
